Tucson suggests that an FDA-approved osteoporosis treatment could help restore the shape of a mutated protein and enhance ...

Announcing a new article publication for Cardiovascular Innovations and Applications journal. Radiation-induced cardiomyopathy has become a significant clinical challenge with the increased use of ...

New real-world data suggest that two out of every five patients with transthyretin amyloid cardiomyopathy treated with ...

This group of pathological conditions includes dilated cardiomyopathy, hypertrophic cardiomyopathy, restrictive cardiomyopathy ... diagnosis and treatment. The authors also discuss permissive ...

Palo Alto, California Thursday, February 13, 2025, 12:00 Hrs [IST] ...

The European Commission has granted marketing authorization in the European Union (EU) for acoramidis, under the brand name ...

Pharma announced the European Commission has granted marketing authorization in the European Union for acoramidis, under the ...

The approval is based on positive results from the Phase 3 ATTRibute-CM study, in which acoramidis demonstrated the most ...

Not following medications and poor lifestyle are ... endocarditis (50.0%), congenital heart disease (34.6%), and restrictive cardiomyopathy (36.8%) compared with other causes of heart failure.

Several disease-modifying therapies (DMTs) can help change the disease course of MS. People with MS can also take other medications for symptoms, complications, and relapses. Multiple sclerosis ...

Ashley Brooks, a two-time heart transplant recipient, is now a heart disease awareness advocate, encouraging others to wear red on February 7 to save lives.